The company has successfully completed a directed share issue, which will provide it with a gross proceed of approximately SEK 324 million. The board of directors of Immunovia has resolved

The agreement will allow it to expand the company’s US offering with products that are complementary to Cerament, it states. The company will start selling and marketing selected Collagen Matrix

Bonesupport Holding AB announces that their current distribution agreement has been terminated and will be replaced by a network of independent distributors and its own commercial organization. This will allow

The company has been chosen as sole supplier to a screening project for atrial fibrillation in Great Britain. The project is the largest longterm screening project with the aim to

The company has received market approval for the time-lapse incubator EmbryoScope+ in the USA, the world’s third largest market measured in terms of number of IVF treatments. EmbryoScope+ is a

Norway Health Tech has visited Canada as part of the delegation of the minister of health and care, Bent Høie. At the visit in Canada, the minister of health and